Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 22, 2023
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
[ Wed, Feb 22nd 2023
] - WOPRAI
Charlie Chan Downgraded (ACMR) to Sell and Held Target at $10 on, Feb 22nd, 2023
Charlie Chan of Morgan Stanley, Downgraded "ACM Research, Inc." (ACMR) to Sell and Held Target at $10 on, Feb 22nd, 2023.
Charlie has made no other calls on ACMR in the last 4 months.
There are 2 other peers that have a rating on ACMR. Out of the 2 peers that are also analyzing ACMR, 1 agrees with Charlie's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Nick Cheng of "Jefferies" Upgraded from Sell to Hold and Decreased Target to $7 on, Monday, November 7th, 2022
This is the rating of the analyst that currently disagrees with Charlie
- Quinn Bolton of "Needham" Maintained at Strong Buy with Increased Target to $12 on, Tuesday, January 31st, 2023
